Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute and long-term safety and tolerability of risperidone in children with autism.
Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. Aman MG, et al. Among authors: chuang s. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84. doi: 10.1089/cap.2005.15.869. J Child Adolesc Psychopharmacol. 2005. PMID: 16379507 Clinical Trial.
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B. McDougle CJ, et al. Am J Psychiatry. 2005 Jun;162(6):1142-8. doi: 10.1176/appi.ajp.162.6.1142. Am J Psychiatry. 2005. PMID: 15930063 Free article. Clinical Trial.
Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E. Arnold LE, et al. Among authors: chuang s. J Am Acad Child Adolesc Psychiatry. 2003 Dec;42(12):1443-50. doi: 10.1097/00004583-200312000-00011. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 14627879 Clinical Trial.
Safety and tolerability of methylphenidate in preschool children with ADHD.
Wigal T, Greenhill L, Chuang S, McGOUGH J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCRACKEN J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A. Wigal T, et al. Among authors: chuang s. J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1294-1303. doi: 10.1097/01.chi.0000235082.63156.27. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17028508 Clinical Trial.
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.
Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB. Arnold LE, et al. Among authors: chuang s. J Child Adolesc Psychopharmacol. 2010 Apr;20(2):83-93. doi: 10.1089/cap.2009.0022. J Child Adolesc Psychopharmacol. 2010. PMID: 20415603 Free PMC article.
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.
McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, Arnold LE, Vitiello B, Whelan F, Chuang SZ, Davies M, Shah B, McDougle CJ, Nurmi EL. McCracken JT, et al. Among authors: chuang sz. Pharmacogenomics J. 2014 Jun;14(3):295-302. doi: 10.1038/tpj.2013.23. Epub 2013 Jul 16. Pharmacogenomics J. 2014. PMID: 23856854 Free PMC article.
Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins S, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL. Posner K, et al. Among authors: chuang sz. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):547-62. doi: 10.1089/cap.2007.0075. J Child Adolesc Psychopharmacol. 2007. PMID: 17979577 Clinical Trial.
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E, Scharko AM, McGough JJ, Murray DW, Evans L, Swanson JM, Wigal T, Posner K, Cunningham C, Davies M, Skrobala AM. Ghuman JK, et al. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):563-80. doi: 10.1089/cap.2007.0071. J Child Adolesc Psychopharmacol. 2007. PMID: 17979578 Clinical Trial.
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Abikoff HB, Vitiello B, Riddle MA, Cunningham C, Greenhill LL, Swanson JM, Chuang SZ, Davies M, Kastelic E, Wigal SB, Evans L, Ghuman JK, Kollins SH, McCracken JT, McGough JJ, Murray DW, Posner K, Skrobala AM, Wigal T. Abikoff HB, et al. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):581-92. doi: 10.1089/cap.2007.0068. J Child Adolesc Psychopharmacol. 2007. PMID: 17979579 Clinical Trial.
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Vitiello B, Abikoff HB, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, Swanson JM, Wigal T, McGough JJ, Ghuman JK, Wigal SB, Skrobala AM, Davies M, Posner K, Cunningham C, Greenhill LL. Vitiello B, et al. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):593-604. doi: 10.1089/cap.2007.0058. J Child Adolesc Psychopharmacol. 2007. PMID: 17979580
2,250 results